| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Taysha Gene Therapies, Inc. (TSHA) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 8 sells. TSHA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.84M | $19.52M | - | |
| CFO | 1.44M | $9.91M | - | |
| Dir | 1.16M | $7.94M | - | |
| Pres | 1.12M | $7.68M | - | |
| CEO | 648.0K | $4.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Alam Kamran83 | Chief Financial Officer | Sell | 1,655 | $4.52 | $7,480.60 | -0.1% | +39.4% | - | |
| Jan 12, 2026 | Nagendran Sukumar49 | President And Head Of R&D | Sale+OE | 200,000 | $4.71 | $942,000.00 | -16.6% | -7.6% | - | |
| Dec 1, 2025 | Nagendran Sukumar49 | President And Head Of R&D | Sale+OE | 370,172 | $4.58 | $1,695,905.72 | -15.5% | +2.3% | - | |
| Sep 10, 2025 | Nagendran Sukumar49 | President And Head Of R&D | Sale+OE | 200,000 | $3.23 | $646,000.00 | -16.6% | +63.4% | - | |
| Aug 21, 2025 | Nagendran Sukumar49 | President And Head Of R&D | Sell | 57,054 | $2.85 | $162,603.90 | -4.7% | +39.7% | - | |
| Aug 21, 2025 | Alam Kamran83 | Chief Financial Officer | Sell | 54,491 | $2.85 | $155,299.35 | -4.4% | +39.7% | - | |
| May 30, 2025 | Manning Paul B53 | 10% Owner | Buy | 750,000 | $2.75 | $2,062,500.00 | +35.9% | +4.4% | - | |
| Jun 27, 2024 | Manning Paul B53 | 10% Owner | Buy | 1,333,333 | $2.25 | $2,999,999.25 | New | -7.2% | +9.9% | |
| Nov 17, 2023 | Manning Paul B53 | 10% Owner | Buy | 100,000 | $1.63 | $163,000.00 | +0.6% | -6.5% | +21.2% | |
| Aug 24, 2023 | Alam Kamran83 | Chief Financial Officer | Sell | 33,000 | $2.33 | $76,890.00 | -11.3% | -21.4% | -6.0% |